86 related articles for article (PubMed ID: 15623805)
1. Succinate dehydrogenase D variants do not constitute a risk factor for developing C cell hyperplasia or sporadic medullary thyroid carcinoma.
Cascon A; Cebrian A; Pollan M; Ruiz-Llorente S; Montero-Conde C; Leton R; Gutierrez R; Lesueur F; Milne RL; Gonzalez-Albarran O; Lucas-Morante T; Benitez J; Ponder BA; Robledo M
J Clin Endocrinol Metab; 2005 Apr; 90(4):2127-30. PubMed ID: 15623805
[TBL] [Abstract][Full Text] [Related]
2. C-cell hyperplasia and medullary thyroid carcinoma: clinicopathological and genetic correlations in 66 consecutive patients.
Guyétant S; Josselin N; Savagner F; Rohmer V; Michalak S; Saint-André JP
Mod Pathol; 2003 Aug; 16(8):756-63. PubMed ID: 12920219
[TBL] [Abstract][Full Text] [Related]
3. The influence of gender, age, and RET polymorphisms on C-cell hyperplasia and medullary thyroid carcinoma.
Weinhaeusel A; Scheuba C; Lauss M; Kriegner A; Kaserer K; Vierlinger K; Haas OA; Niederle B
Thyroid; 2008 Dec; 18(12):1269-76. PubMed ID: 18976163
[TBL] [Abstract][Full Text] [Related]
4. No mutations but an increased frequency of SDHx polymorphisms in patients with sporadic and familial medullary thyroid carcinoma.
Montani M; Schmitt AM; Schmid S; Locher T; Saremaslani P; Heitz PU; Komminoth P; Perren A
Endocr Relat Cancer; 2005 Dec; 12(4):1011-6. PubMed ID: 16322339
[TBL] [Abstract][Full Text] [Related]
5. [Thyroid C cells and their pathology: Part 1: normal C cells, - C cell hyperplasia, - precursor of familial medullary thyroid carcinoma].
Ting S; Synoracki S; Schmid KW
Pathologe; 2015 May; 36(3):246-53. PubMed ID: 25898937
[TBL] [Abstract][Full Text] [Related]
6. Pentagastrin stimulation test and early diagnosis of medullary thyroid carcinoma using an immunoradiometric assay of calcitonin: comparison with genetic screening in hereditary medullary thyroid carcinoma.
Barbot N; Calmettes C; Schuffenecker I; Saint-André JP; Franc B; Rohmer V; Jallet P; Bigorgne JC
J Clin Endocrinol Metab; 1994 Jan; 78(1):114-20. PubMed ID: 7904611
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels.
Milone F; Ramundo V; Chiofalo MG; Severino R; Paciolla I; Pezzullo L; Lombardi G; Colao A; Faggiano A
Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894
[TBL] [Abstract][Full Text] [Related]
8. [Mutations of ret-proto-oncogene in thyroid medullary carcinoma].
Frank-Raue K; Höppner W; Buhr H; Herfarth C; Ziegler R; Raue F
Dtsch Med Wochenschr; 1997 Feb; 122(6):143-9. PubMed ID: 9081799
[TBL] [Abstract][Full Text] [Related]
9. A novel germ-line point mutation in RET exon 8 (Gly(533)Cys) in a large kindred with familial medullary thyroid carcinoma.
Da Silva AM; Maciel RM; Da Silva MR; Toledo SR; De Carvalho MB; Cerutti JM
J Clin Endocrinol Metab; 2003 Nov; 88(11):5438-43. PubMed ID: 14602786
[TBL] [Abstract][Full Text] [Related]
10. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels.
Iacobone M; Niccoli-Sire P; Sebag F; De Micco C; Henry JF
World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469
[TBL] [Abstract][Full Text] [Related]
11. RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center.
Elisei R; Romei C; Cosci B; Agate L; Bottici V; Molinaro E; Sculli M; Miccoli P; Basolo F; Grasso L; Pacini F; Pinchera A
J Clin Endocrinol Metab; 2007 Dec; 92(12):4725-9. PubMed ID: 17895320
[TBL] [Abstract][Full Text] [Related]
12. Absence of RET gene point mutations in sporadic thyroid C-cell hyperplasia.
Saggiorato E; Rapa I; Garino F; Bussolati G; Orlandi F; Papotti M; Volante M
J Mol Diagn; 2007 Apr; 9(2):214-9. PubMed ID: 17384213
[TBL] [Abstract][Full Text] [Related]
13. C-cell hyperplasia in sporadic and familial medullary thyroid carcinoma.
Yadav M; Agrawal V; Pani KC; Verma R; Jaiswal S; Mishra A; Pandey R
Indian J Pathol Microbiol; 2018; 61(4):485-488. PubMed ID: 30303134
[TBL] [Abstract][Full Text] [Related]
14. Association of mitochondrial DNA transversion mutations with familial medullary thyroid carcinoma/multiple endocrine neoplasia type 2 syndrome.
Abu-Amero KK; Alzahrani AS; Zou M; Shi Y
Oncogene; 2006 Feb; 25(5):677-84. PubMed ID: 16205644
[TBL] [Abstract][Full Text] [Related]
15. Proliferative activity in C-cell hyperplasia and medullary thyroid carcinoma. Evaluation by PCNA immunohistochemistry and AgNORs staining.
Matias-Guiu X; Peiro G; Esquius J; Oliva E; Cabezas R; Colomer A; Prat J
Pathol Res Pract; 1995 Feb; 191(1):42-7. PubMed ID: 7651932
[TBL] [Abstract][Full Text] [Related]
16. Polysialic acid of the neural cell adhesion molecule in the human thyroid: a marker for medullary thyroid carcinoma and primary C-cell hyperplasia. An immunohistochemical study on 79 thyroid lesions.
Komminoth P; Roth J; Saremaslani P; Matias-Guiu X; Wolfe HJ; Heitz PU
Am J Surg Pathol; 1994 Apr; 18(4):399-411. PubMed ID: 8141431
[TBL] [Abstract][Full Text] [Related]
17. Occurrence of the Cys611Tyr mutation and a novel Arg886Trp substitution in the RET proto-oncogene in multiple endocrine neoplasia type 2 families and sporadic medullary thyroid carcinoma cases originating from the central region of Portugal.
Prazeres HJ; Rodrigues F; Figueiredo P; Naidenov P; Soares P; Bugalho MJ; Lacerda M; Campos B; Martins TC
Clin Endocrinol (Oxf); 2006 Jun; 64(6):659-66. PubMed ID: 16712668
[TBL] [Abstract][Full Text] [Related]
18. Tenascin C in medullary thyroid microcarcinoma and C-cell hyperplasia.
Koperek O; Prinz A; Scheuba C; Niederle B; Kaserer K
Virchows Arch; 2009 Jul; 455(1):43-8. PubMed ID: 19484261
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemistry of medullary thyroid carcinoma and C-cell hyperplasia by an affinity-purified anti-human calcitonin antiserum.
Hayashida CY; Alves VA; Kanamura CT; Ezabella MC; Abelin NM; Nicolau W; Bisi H; Toledo SP
Cancer; 1993 Aug; 72(4):1356-63. PubMed ID: 8339225
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of the RET proto-oncogene key exons in patients with medullary thyroid carcinoma: a comprehensive study of the Iranian population.
Alvandi E; Akrami SM; Chiani M; Hedayati M; Nayer BN; Tehrani MR; Nakhjavani M; Pedram M
Thyroid; 2011 Apr; 21(4):373-82. PubMed ID: 21309721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
